Article Image
News Link • Drugs and Medications

The “Shadow Pharmaceutical” Sector

•, By Patrick Cox

The business of medical biotechnologies operates within an extraordinarily complex regulatory system.

The SEC and the IRS are only the beginning of the story…

In the United States, the Food and Drug Administration determines what can legally be sold. It even exercises control over what can be said by companies about medical therapies. Elsewhere, other regulatory authorities play similar roles.

It was not always that way, of course. Prior to the 20th century, there was virtually no regulation of medical therapies. Medical decisions were considered the domain of doctors and patients, who bore the responsibilities and risks associated with the use of any product. Even currently banned Class A drugs used for recreational purposes were available for sale without limitations.

Join us on our Social Networks:


Share this page with your friends on your favorite social network: